Abstract

The C‐terminal guanine exchange factor module of Trio (TrioC) activates the small G protein RhoA, linking Gαq/11‐coupled 7TM receptors to cellular events including cytoskeletal rearrangements and gene transcription. This signal transduction pathway underlies the development of uveal melanoma, a fatal malignancy. Previous studies have shown that TrioC is regulated via autoinhibition relieved by the binding of Gαq/11. However, the structural determinants of the autoinhibited state have remained elusive. We determined the crystal structure of TrioC in its basal state, revealing the molecular basis of autoinhibition mediated by the pleckstrin homology (PH) domain via direct interactions with the Rho binding site on the Dbl homology domain (DH). We show that truncation of the PH domain or introduction of point mutations activates the TrioC module in nucleotide exchange assays by liberating the Rho binding site. This model is consistent with results obtained by hydrogen‐deuterium exchange mass spectrometry. Finally, we show that mutations in the PH domain found in cancer patients also hyper‐activate full length TrioC in cell based models. These mutations may thus represent the first known cancer drivers in Trio that operate in an analogous, yet Gαq/11‐independent manner.Support or Funding InformationThis work was supported by NIH Grants CA221289, HL122416, and HL071818 (to J.J.G.T.), 5T32GM007767‐38, 5T32GM007767‐39, and F31CA224804 (to S.J.B.), and 5T32GM007752‐39 (to N.A.). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE‐AC02‐06CH11357. Use of the LS‐CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri‐Corridor (Grant 085P1000817).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.